| abstract |
FIELD: medicine. n SUBSTANCE: what is presented is a group of inventions; it involves a method for activating the health recovery of an involved respiratory epithelial cell an injury of which is related to cough, post-viral or -bacterial infection, acute/chronic bronchitis or chronic obstructive pulmonary disease (COPD) by administering a compound of formula and/or formula , a composition for the same application on the basis of the above compound, a respective method of treating an inflammatory respiratory condition, a pharmaceutical composition for treating the inflammatory respiratory condition, and using the compound of formula (1) and/or formula (2) for preparing the therapeutic agent for treating cough, post-viral or -bacterial, acute/chronic bronchitis or COPD. n EFFECT: health recovery of the respiratory cell for 48 hours as shown by sialylated glycoconjugates on its surface after treatment with influenza virus or bacterium neuraminidase, as well as reducing a rate of cough in guinea pigs sensitised with citric acid solution. n 10 cl, 37 ex |